Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Angela K. Kuehl"'
Publikováno v:
Psychosomatics. 53:541-549
Background Phenylketonuria (PKU) is a neuropsychiatric disease with a genetically transmitted metabolic etiology. A large percentage of untreated, early-treated, and continuously treated patients with PKU suffer from neurocognitive and neuropsychiatr
Publikováno v:
Psychosomatics. 53:517-523
Phenylketonuria (PKU) is an autosomal recessive metabolic genetic disorder that is associated with neuropsychiatric sequelae of varying severity. The natural history, epidemiology, and a history of the medical understanding and approaches to treatmen
Autor:
Peter S. Thorne, Kevin M. Kelly, Elizabeth A. Chrischilles, Angela K. Kuehl, Leon F. Burmeister, James A. Merchant, Richard C. Ahrens
Publikováno v:
Journal of Allergy and Clinical Immunology. 113:66-71
Background There are conflicting findings about the prevalence of asthma among farm and nonfarm children. Objectives We sought to estimate asthma prevalence and morbidity and determine differences between farm and nonfarm children. Methods The study
Publikováno v:
Journal of the American Pharmaceutical Association (1996). 37:182-191
Objective: To develop and present a pharmaceutical care training program for pharmacists, and to examine the ability of these pharmacists to provide pharmaceutical care in a community pharmacy setting. Design: Prospective, randomized study. Intervent
Publikováno v:
Journal of the American Pharmaceutical Association (Washington, D.C. : 1996). 38(3)
Objectives A system for exchanging patient information among hospital, long-term-care (LTC), and ambulatory care pharmacies is described, and the influence of that system on pharmacist interventions is reported. Methods Study sites consisted of three
Autor:
Saleem E. Noormohamed, Angela K. Kuehl
Publikováno v:
The Annals of pharmacotherapy. 29(7-8)
Recombinant erythropoietin (Epogen, Amgen Pharmaceuticals; Procrit, Amgen Pharmaceuticals, distributed by Ortho Biotech) is approved for use in anemia associated with HIV infection and treatment. The recommended starting dose is 100 IU/kg iv or sc 3
Autor:
R.E. Walker, Marsha E. O'Neill, Elizabeth A. Chrischilles, L.M. Harris, Nervana Metwali, Kevin M. Kelly, A.K. Quella, Peter S. Thorne, Angela K. Kuehl
Publikováno v:
Journal of Allergy and Clinical Immunology. 117:S215